SCHEMBL4698269

SCHEMBL4698269

CN1CCC2CNC=C21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27035778 0.64 PLG (0.38)
SCHEMBL19122656 0.61
SCHEMBL20457669 0.57
SCHEMBL375904 0.55
SCHEMBL29465177 0.54
SCHEMBL29465156 0.54
SCHEMBL28027264 0.52
SCHEMBL7948348 0.51
SCHEMBL29465180 0.50
SCHEMBL13602035 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2001885-A2 OCTAHYDRO-PYRROLO[3,4-B]PYRROLE DERIVATIVES Abbott Laboratories (US) 2008-12-17 EP claimed
WO-2007100990-A2 OCTAHYDRO-PYRROLO[3,4-B] PYRROLE DERIVATIVES AND THEIR USE AS HISTAMINE-3 RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 2007-09-07 WO claimed
US-20250304577-A1 TYK2 INHIBITORS BIOGEN MA INC. 2025-10-02 US disclosed
CN-114573604-B Quinolone-based compound, preparation method thereof, pharmaceutical composition containing quinolone-based compound and application of quinolone-based compound 中国科学院上海药物研究所 2024-06-18 CN disclosed
CN-106928200-A For the pyrrolotriazine derivatives for the treatment of cancer 湖南福沃药业有限公司 2017-07-07 CN disclosed